MRTX1133 CLINICAL THINGS TO KNOW BEFORE YOU BUY

The identification of KRASG12C inhibitors has reignited fascination in targeting RAS proteins. This work describes the invention from the KRASG12D-specific inhibitor MRTX1133 and demonstrates the feasibility of potently and selectively focusing on this oncogenic variant.These findings, Dr. Luo reported, advise that MRTX1133 will help enlist the imm